Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)

SKU: orb1818397

This product can be custom made

Description

Recombinant Antibody

Images & Validation

−

Item 1 of 3

Tested Applications	ELISA, FC
Reactivity	Human

Key Properties

−

Antibody Type	Primary Antibody
Clonality	Monoclonal
Isotype	IgG1
Source/Expression System	CHO Cell
Protein Sequence	TNFRSF8 / CD30
Molecular Weight	145.48
Endotoxin	< 0.001EU/μg,determined by LAL method.
Conjugation	Unconjugated

Storage & Handling

−

Form/Appearance	Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column.
Concentration	1mg/ml
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Tumor necrosis factor receptor superfamily member 8 {ECO:0000312|HGNC:HGNC:11923}, CD30L receptor, Ki-1 antigen, Lymphocyte activation antigen CD30, CD30, TNFRSF8 (HGNC:11923)

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

The purity of Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin) is more than 98.99%, determined by SEC-HPLC.

Immobilized human CD30 His at 2 µg/mL can bind Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin), EC50=0.006007 µg/mL

Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%